Home
>
National Drug Code (NDC)
>
Exelon
Exelon - 54868-5240-0 - (rivastigmine tartrate)
Drug Information of Exelon
| Product NDC: | 54868-5240 |
| Proprietary Name: | Exelon |
| Non Proprietary Name: | rivastigmine tartrate |
| Active Ingredient(s): | 4.5 mg/1 & nbsp; rivastigmine tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Exelon
| Product NDC: | 54868-5240 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020823 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050303 |
Package Information of Exelon
| Package NDC: | 54868-5240-0 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (54868-5240-0) |
NDC Information of Exelon
| NDC Code | 54868-5240-0 |
| Proprietary Name | Exelon |
| Package Description | 30 CAPSULE in 1 BOTTLE (54868-5240-0) |
| Product NDC | 54868-5240 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rivastigmine tartrate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20050303 |
| Marketing Category Name | NDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | RIVASTIGMINE TARTRATE |
| Strength Number | 4.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
